Axcella Health Inc. (AXLA)
Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
Address
840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Founded
2008
Number of Employees
11
Website
http://www.axcellahealth.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)